Condition | Model | Cell source | Administration route | Results | Ref. |
---|---|---|---|---|---|
SCI | Mice | BM | Intravenous | Stimulating functional behavioral restoration via improving M2/M1 macrophage ratio by exosomal miR-216a-5p | [120] |
SCI | Rat | AM | Intravenous | Reducing inflammation and eliciting antioxidant effects through MSC-derived exosomes immobilized in hydrogel | [138] |
SCI | Rat | UC | Intrathecal | Plummeting pro-inflammatory cytokine TNF-α and IL-1β, while improving IL-10, BDNF, and GDNF levels in brain tissue | [164] |
SCI | Rat | BM | Intravenous | Alleviating neurological damage through suppressing Ern1 and promoting M2 macrophage by exosomal microRNA-124-3p | [165] |
SCI | Rat | BM | Intravenous | Repairing spinal cord injury by exosomal miRNA-29b | [166] |
SCI | Rat | BM | Intravenous | Repairing spinal cord injury by inhibition of A1 neurotoxic reactive astrocytes activation | [117] |
SCI | Rat | UC | Intrathecal | Reducing the c-Fos, GFAP, Iba1, TNF-α, and IL-1β, and improving IL-10 and GDNF levels | [137] |
SCI | Rat | BM | Intravenous | Inhibition of pericytes migration and improving the BSCB integrity by targeting NF-κB p65 signaling in pericytes | [133] |
SCI | Mice | BM | Intraspinal | Promoting angiogenesis and axon growth leading to the functional rescue | [167] |
SCI | Rat | BM | Intravenous | Promoting the neurogenesis and angiogenesis, while reducing apoptosis by exosomal miR-126 | [128] |
SCI | Rat | BM | Intravenous | Hindrance of complement activation | [168] |
SCI | Mice | Placental | Intrathecal | Potentiating angiogenesis leading to the ameliorated neurologic function | [129] |
SCI | Rat | BM | Intravenous | Improving M2 macrophage polarization | [121] |
SCI | Rat | UC | Intravenous | Exerting anti-inflammatory and anti-fibrotic action | [169] |
SCI | Rat | NA | Intravenous | Attenuation of inflammation through down-regulation of TLR4/NF-κB signaling pathway by exosomal miR-145-5p | [170] |
SCI | Rat | BM | Intravenous | Inhibition of A1 neurotoxic reactive astrocytes activation in part via suppressing NF-κB translocation | [118] |
TBI | Rat | BM | Intravenous | Promoting functional recovery through triggering endogenous angiogenesis and neurogenesis and also down-regulation of neuroinflammation | [104] |
TBI | Rat | AT | Intracerebroventricular | Reducing microglia activation | [145] |
TBI | Rat | BM | Intravenous | Amelioration of sensorimotor and cognitive dysfunction, attenuation of hippocampal neuronal cell loss, inducing the angiogenesis and neurogenesis, and mitigation of neuroinflammation | [143] |
TBI | Rat | BM | Intranasal | Exosome efficient migration to the injured Forebrain | [171] |
TBI | Rat | BM | Intravenous | Amelioration of neurological functions, decreasing brain edema through favoring BBB integrity | [23] |
TBI | Swine | BM | Intravenous | Boosting neural plasticity along with reducing inflammation and apoptosis ensuring reduced brain lesion zone | [147] |
TBI | Mice | BM | Intraorbital | Mitigation of early inflammatory responses | [144] |
TBI | Rat | BM | Intravenous | Triggering endogenous angiogenesis and neurogenesis | [142] |
TBI | Swine | BM | Intravenous | Induction of neuroprotection and supporting BBB integrity | [90] |
TBI | Rat | BM | Intravenous | Stimulating neuroprotection via exosomal miR-216a-5p, which up-regulates BDNF expression | [172] |
TBI | Mice | BM | Intravenous | Amelioration of cognitive deficits | [173] |
Stroke | Mice | AT | Intravenous | Reducing autophagy by exosomal miR-25 | [174] |
Stroke | Rat | BM | Intravenous | Stimulation of neuritis outgrowth by exosomal miR-133b | [163] |
Stroke | Mice | BM | Intravenous | Obstruction of neuroinflammation and averting cerebral infarction by exosomal miR-542-3p | [175] |
Stroke | Mice | UC | Intravenous | Attenuation of microglial-mediated neuroinflammation through down-regulation of the IRAK1/TRAF6 signaling axis by exosomal miR-146a-5p | [159] |
Stroke | Rat | BM | Intravenous | Promoting the neurorestorative effects | [176] |
Stroke | Rat | BM | Intravenous | Suppression of the neuronal apoptosis and M1 macrophage polarization by exosomal miR-146a-5p causes alleviated intracerebral hemorrhage | [177] |
Stroke | Mice | BM | Intravenous | Induction of neuroprotection | [178] |
Stroke | Rat | BM | Intravenous | Improving the functional recovery and neurovascular plasticity | [179] |
Stroke | Rat | UCB | Intravenous | Triggering the functional recovery | [180] |
Stroke | Rat | AT | Intravenous | Attenuation of the ischemic brain injuries by targeting miR-21-3p/MAT2B axis | [181] |
Stroke | Rat | BM | Intravenous | Promoting the axon–myelin remodeling by exosomal miR-17-92 | [182] |
Stroke | Mice | BM | Intravenous | Reducing inflammation, pathological alterations and apoptosis by exosomal miR-221-3p | [183] |